SANUWAVE Health Inc(US:SNWV)2025-05-26 19:09Financial Performance - Sanuwave Health, Inc achieved record quarterly revenues of $72 million in Q2 2024, a 53% increase compared to $47 million in Q2 2023[13, 15] - Gross margin for Q2 2024 was 73%, slightly down from 74% in Q2 2023[14, 15] - GAAP Operating Income reached $20 million in Q2 2024, an improvement of $11 million from Q2 2023[14, 15] - Net income for Q2 2024 was $66 million, compared to a net loss of $73 million in Q2 2023[15] - Adjusted EBITDA for Q2 2024 was $15 million, a significant increase from $171 thousand in Q2 2023[16] Revenue Drivers - UltraMist consumables revenue increased by 67% to $47 million in Q2 2024, representing 65% of total revenues, compared to $28 million in the same quarter last year[15] - 72 UltraMist systems were sold in Q2 2024, up from 49 in Q2 2023 and 43 in Q1 2024[15] Future Outlook - The company forecasts Q3 2024 revenue to increase by 65-75% compared to Q3 2023, projecting revenues of $8-85 million[14, 17] Capital Structure - Sanuwave secured 100% participation in its note and warrant exchange offer, simplifying the company's capital structure[18]